SCHEMBL19783265

SCHEMBL19783265

N=CC(=O)COc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.61
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
PTPN7 P35236 1/20 0.49
PTPN12 Q05209 1/20 0.49
ALPL P05186 1/20 0.49
ALPI P09923 1/20 0.49
ALPG P10696 1/20 0.49
GAA P10253 2/20 0.47
RAB9A P51151 2/20 0.47
GLA P06280 1/20 0.47
HTT P42858 1/20 0.47
HPGD P15428 1/20 0.47
FFAR1 O14842 1/20 0.46
NPC1 O15118 1/20 0.45
MAOB P27338 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31172364 0.82 ALOX15 (0.63) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL11367180 0.80 ALOX15 (0.61) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL11008229 0.80 ALOX15 (0.61) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL5497407 0.80 ALOX15 (0.61) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL10656399 0.77 ALOX15 (0.57) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL953683 0.77 ALOX15 (0.68) ALOX15KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL8127 0.76 ALOX15 (1.00) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL1318870 0.76 ALOX15 (1.00) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL3898377 0.76 ALOX15 (0.74) ALOX15KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL9725995 0.76 CYP1A2 (0.61) ALOX15KMT2AMEN1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
EP-3442961-B1 AGRICULTURAL CHEMICALS REDAG CROP PROT LTD (GB) 2021-03-24 EP disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 ALOX15 1358/4885KMT2A 2420/4885MEN1 1767/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 ALOX15 1313/4885KMT2A 2390/4885MEN1 1492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.